Dynavax Technologies
DVAX
#4957
Rank
โ‚ฌ1.54 B
Marketcap
13,13ย โ‚ฌ
Share price
0.00%
Change (1 day)
2.52%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: โ‚ฌ1.54 Billion

As of February 2026 Dynavax Technologies has a market cap of โ‚ฌ1.54 Billion. This makes Dynavax Technologies the world's 4957th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ1.54 B0.32%
2025โ‚ฌ1.53 B-6.38%
2024โ‚ฌ1.64 B0.46%
2023โ‚ฌ1.63 B29.17%
2022โ‚ฌ1.26 B-15.08%
2021โ‚ฌ1.49 B273.82%
2020โ‚ฌ0.39 B-6.91%
2019โ‚ฌ0.42 B-14.82%
2018โ‚ฌ0.50 B-46.76%
2017โ‚ฌ0.94 B552.75%
2016โ‚ฌ0.14 B-82.97%
2015โ‚ฌ0.84 B132.94%
2014โ‚ฌ0.36 B-2.22%
2013โ‚ฌ0.37 B-5.3%
2012โ‚ฌ0.39 B21.49%
2011โ‚ฌ0.32 B16.56%
2010โ‚ฌ0.27 B417%
2009โ‚ฌ53.79 M124.66%
2008โ‚ฌ23.94 M-82.79%
2007โ‚ฌ0.13 B-49.63%
2006โ‚ฌ0.27 B228.41%
2005โ‚ฌ84.13 M-39.74%
2004โ‚ฌ0.13 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚ฌ128.40 B 8,225.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ171.18 B 10,999.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ23.88 B 1,448.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ159.17 B 10,220.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ258.77 B 16,678.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ268.25 B 17,293.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ101.20 B 6,462.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
โ‚ฌ93.71 M-93.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ33.77 B 2,089.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel